Bayer fundamentally disagrees with EFSA’s updated risk assessment conclusions for the active substances imidacloprid and clothianidin.
Unfortunately, EFSA chose to base its assessment on an unworkable guidance document that makes it impossible to field a study that would not find risk, despite repeated requests by Member States for a review of this guidance. To date, and for this reason, the guidance has not been adopted by EU Member States.
In non-EU countries where neonicotinoids are intensively used in agriculture and the bee safety of these has also been subject to a thorough examination, authorities came to fundamentally different conclusions than those of the European regulators.
Here you can find the link to the Bayer Press Release
The Bayer Bee Care Position: